Patents Assigned to INVIVOSCRIBE, INC.
  • Publication number: 20230055466
    Abstract: The present disclosure provides methods of analysing the nucleotide read sequences of a nucleic acid sample of interest using high throughput bidirectional sequencing. The methods of the present disclosure are designed to work even where bidirectional sequencing produces forward and reverse reads that are not of a sufficient read length to be paired via the complementary hybridisation of overlapping sequences at the 3° end of the sequence reads. The disclosure further provides computer-implemented methods, computer-readable storage mediums and devices that implement a method for preparing nucleic acid sequence results for analysis from non-overlapping sequence reads for screening a nucleic acid sample of interest for the expression of one or more target nucleotide sequences.
    Type: Application
    Filed: December 23, 2020
    Publication date: February 23, 2023
    Applicant: INVIVOSCRIBE, INC.
    Inventor: Kasey Robert HUTT
  • Patent number: D1134925
    Type: Grant
    Filed: December 21, 2021
    Date of Patent: July 14, 2026
    Assignee: Invivoscribe, Inc.
    Inventors: Martin Anthony Mottram, Balazs Kiss, Andrew James Malloy